title: [The cornea and synthetic antimalarials].
abstract: The main targets of antimalarial ocular toxicity are the cornea, ciliary body and retina. In sixty patients treated with chloroquine (Nivaquine) 73% showed keratopathy. The clinical features and clinical course of this keratopathy and its relationship with retinopathy were described. In contrast with retinopathy, keratopathy is not contraindication to antimalarial treatment.
authors.affiliation: Institut Hédi Rais d'Ophtalmologie, Tunis, Tunisie.
authors.forename: A
authors.initials: A
authors.lastname: Jeddi
authors.forename: N
authors.initials: N
authors.lastname: Ben Osman
authors.forename: F
authors.initials: F
authors.lastname: Daghfous
authors.forename: H
authors.initials: H
authors.lastname: Bouguila
authors.forename: O
authors.initials: O
authors.lastname: Charfi
authors.forename: S
authors.initials: S
authors.lastname: Ayed
mesh_terms: D000293:Adolescent; D000328:Adult; D000962:Antimalarials / Q000009:adverse effects*; D002738:Chloroquine / Q000008:administration & dosage / Q000009:adverse effects; D003316:Corneal Diseases / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012164:Retinal Diseases / Q000139:chemically induced / Q000503:physiopathology; D012307:Risk Factors
chemical_list: D000962:Antimalarials; D002738:Chloroquine
vernacular_title: Cornée et antipaludéens de synthèse.